We are live on ! Find out more
ASTH icon

Astrana Health

179 hedge funds and large institutions have $822M invested in Astrana Health in 2024 Q4 according to their latest regulatory filings, with 31 funds opening new positions, 68 increasing their positions, 54 reducing their positions, and 41 closing their positions.

New
Increased
Maintained
Reduced
Closed

1,466% more call options, than puts

Call options by funds: $14.4M | Put options by funds: $921K

26% more repeat investments, than reductions

Existing positions increased: 68 | Existing positions reduced: 54

1.32% more ownership

Funds ownership: 45%46.33% (+1.3%)

0% more funds holding in top 10

Funds holding in top 10: 11 (0)

5% less funds holding

Funds holding: 189179 (-10)

24% less first-time investments, than exits

New positions opened: 31 | Existing positions closed: 41

44% less capital invested

Capital invested by funds: $1.47B → $822M (-$644M)

Holders
179
Holders Change
-10
Holders Change %
-5.29%
% of All Funds
2.36%
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.01%
New
31
Increased
68
Reduced
54
Closed
41
Calls
$14.4M
Puts
$921K
Net Calls
+$13.5M
Net Calls Change
-$20.5M
Name Holding Trade Value Shares
Change
Change in
Stake
BlackRock
1
BlackRock
New York
$203M +$2.61M +55,030 +0.9%
Vanguard Group
2
Vanguard Group
Pennsylvania
$148M +$986K +20,757 +0.4%
State Street
3
State Street
Massachusetts
$52.5M +$3.76M +79,238 +5%
Fidelity Investments
4
Fidelity Investments
Massachusetts
$39.5M +$19.8M +416,959 +50%
Dimensional Fund Advisors
5
Dimensional Fund Advisors
Texas
$33M +$4.81M +101,192 +11%
Geode Capital Management
6
Geode Capital Management
Massachusetts
$32.1M -$59K -1,243 -0.1%
3C
7
325 Capital
New York
$28M +$9.78M +206,009 +30%
SW
8
SteelPeak Wealth
California
$17.1M -$6.55M -138,000 -20%
Charles Schwab
9
Charles Schwab
California
$14.9M +$1.12M +23,533 +5%
Northern Trust
10
Northern Trust
Illinois
$14.7M +$2.04M +43,032 +10%
NAM
11
NorthCrest Asset Manangement
Minnesota
$14.2M -$570K -11,993 -3%
Morgan Stanley
12
Morgan Stanley
New York
$13M +$3.32M +69,834 +20%
Goldman Sachs
13
Goldman Sachs
New York
$11.4M +$4.91M +103,291 +40%
Loomis, Sayles & Company
14
Loomis, Sayles & Company
Massachusetts
$10.1M -$9.62M -202,443 -39%
Bank of New York Mellon
15
Bank of New York Mellon
New York
$8.41M -$86.7K -1,826 -0.7%
Royal Bank of Canada
16
Royal Bank of Canada
Ontario, Canada
$8.25M +$333K +7,020 +3%
Invesco
17
Invesco
Georgia
$8.15M +$794K +16,717 +7%
RA
18
Royce & Associates
New York
$8.06M +$6.68M +140,584 +122%
AWS
19
Atria Wealth Solutions
New York
$7.48M
Renaissance Technologies
20
Renaissance Technologies
New York
$6.87M +$7.09M +149,300 +218%
Principal Financial Group
21
Principal Financial Group
Iowa
$6.84M -$667K -14,042 -6%
BG
22
Bellevue Group
Switzerland
$6.47M -$2.32M -48,943 -19%
Jane Street
23
Jane Street
New York
$5.95M -$23M -485,108 -72%
JP Morgan Chase
24
JP Morgan Chase
New York
$5.16M +$4.48M +94,268 +136%
Diamond Hill Capital Management
25
Diamond Hill Capital Management
Ohio
$5.02M +$803K +16,911 +12%

ASTH Hedge Fund Activity: Q4 2024 in Review

179 of the 7,592 institutional investors tracked by Wall St. Rank reported a position in Astrana Health (ASTH) for Q4 2024, worth a combined $822M — down 44% from $1.47B a quarter earlier.

Sellers outnumbered buyers: 41 funds closed out of ASTH and 31 opened new positions — a net loss of 10 holders — while 54 trimmed existing stakes and 68 added.

The largest buyer was Fidelity Investments, adding an estimated $19.8M. The largest seller was Jane Street, cutting an estimated $23M.

  • 179 institutional investors held Astrana Health (ASTH) as of Q4 2024, down from 189 in Q3 2024.
  • Funds reported $822M of Astrana Health stock for Q4 2024, down 44% quarter-over-quarter.
  • 31 funds opened new Astrana Health positions in Q4 2024 and 41 closed out, a net change of -10 holders.
  • The largest Astrana Health buyer in Q4 2024 was Fidelity Investments, an estimated $19.8M added.
  • The largest Astrana Health seller in Q4 2024 was Jane Street, an estimated $23M sold.

Based on aggregated 13F filings for Q4 2024.